VP
Vikram Purohit Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
17
Avg Return
Past Year
Past Year
4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
58.8%
Neutral
41.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Health Information Services
Medical Care Facilities
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Maintained
| $94 |
11%
downside
| 3 | – |
–
| 6 Jan ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $11 |
44%
upside
| 1 | +15% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $34 |
107%
upside
| 1 | -48% |
0
%
| 28 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $79 |
10%
upside
| 5 | +0.62% |
0
%
| 20 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $5.89 |
71%
upside
| 2 | +9.4% |
0
%
| 18 Aug ‘25 4 months ago |
|
|
|
Equal-Weight
Assumed
| $5 |
6%
upside
| 3 | – |
–
| 3 Jul ‘25 6 months ago |
|
|
|
Overweight
Upgraded
| $250 |
20%
upside
| 1 | +21% |
0
%
| 5 May ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $190 |
13%
upside
| 1 | +31% |
0
%
| 27 Feb ‘25 10 months ago |
|